Jorge Emilio Alfonso
Director | HEOR & Market Access
Jorge Emilio Alfonso is a Director in the HEOR & Market Access practice of Monitor Deloitte Belgium with core focus on Life Sciences. His expertise covers value-based pricing, market access, evidence generation & synthesis (indirect comparisons and (network) meta-analyses), health economic modelling for HTA purposes and value communication including the development of value propositions and GVDs. He has sound knowledge of the drug development process and has experience across different therapeutic areas such as oncology (orphan disease), multiple sclerosis, Alzheimer, cardiology, epilepsy, hematology, vaccines and thrombosis.
Jorge has strong knowledge of HTA methodologies and processes across Europe with a proven track record in the successful launching of several blockbusters and has +14 years’ experience in the pharma and medical devices industries.